4. The investigator notifies the clinical Director and the Sponsor within 24 hours of all serious or unexpected events, and the defects of devices that could have led to a serious adverse event, except those conditions that are identified in the protocol (loss of retention of the adhesive restoration) or in the investigator's brochure as not requiring immediate reporting;